Navigation Links
Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015
Date:8/22/2011

a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd. in October 2011 and, in addition, may include statements regarding anticipated scientific progress on its research programs, development of potential pharmaceutical products, interpretation of clinical results, prospects for regulatory approval, manufacturing development and capabilities, market prospects for its products, sales and earnings guidance, and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8-K, 10-Q and 10-K filed with the SEC. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Cephalon does not intend to update publicly any forward-looking statement, except as required by law. The Private Securities Litigation Reform Act of 1995 permits this discussion.Cephalon:Investor Contacts:Media Contacts:Chip Merritt

(610) 738-6376

cmerritt@cephalon.comFritz Bittenbender

Cell: (610) 457-7041

Office: (610) 883-5855

fbittenb@cephalon.comJoseph Marczely

(610) 883-5894

jmarczely@cephalon.comNatalie de Vane

Cell: (610) 999-8756

Office: (610) 727-6536

'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Receives FDA Approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ
2. Cephalon Shareholders Approve Acquisition by Teva
3. Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction
4. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
5. Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
6. Cephalon Lodges Bidders Statement for A$167 Million Offer for ChemGenex Pharmaceuticals
7. Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
8. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
9. Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited
10. Cephalon Wins FENTORA Patent Suit Against Watson
11. Cephalon Announces Definitive Agreement to Acquire Gemin X
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... MALVERN, Pa. , March 31, 2015  SCILEX ... commercialization of products focused on the treatment of pain, ... Tokyo Japan ), a member of ITOCHU ... one of the three leading sogo shosha (general trading ... a strategic investment in SCILEX.  ICF has worked closely ...
(Date:3/31/2015)... 31, 2015  SynCardia Systems, Inc. has received FDA ... study on the effective use of its 50cc SynCardia ... The FDA approval will allow SynCardia ... heart failure patients. Patients enrolled in this study will ... bridge to a donor heart transplant. (Caution-In the ...
(Date:3/31/2015)... /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or the "Company"), ... marijuana products and a licensed producer ("LP") to cultivate ... Canada ) ("MMPR"), is pleased to announce ... the District of Saanich confirming ... now allows for commercial distribution of medical marijuana under ...
Breaking Medicine Technology:SCILEX Pharmaceuticals Announces Strategic Investment By ITOCHU CHEMICAL FRONTIER Corporation 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 3FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 4T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3
(Date:3/31/2015)... Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) ... fraud resulted in $45.4 million in savings -- identified ... -- in 2014. The $45.4 million represents the highest/recovery ... Special Investigations Unit (SIU) in 1983. Since 2005, ... , “Our SIU has progressively enhanced Horizon’s analytics ...
(Date:3/31/2015)... March 31, 2015 An individual’s meniscus ... important ligaments in the leg providing stability, load bearing ... study at today’s Specialty Day meeting of the American ... MRI data to determine the potential for biologic healing ... understood about the healing of meniscus tears when a ...
(Date:3/31/2015)... March 31, 2015 Burns Engineering announces 3-Day ... for the Food & Beverage, Pharmaceutical and Biotech markets. ... are ASME-BPE compliant and are now available as part of ... running. , The S01 and S03 with 1/8” ... Ferrule process connections used in process lines 1/4” and larger. ...
(Date:3/31/2015)... The report “Coagulation/Hemostasis Analyzer Market ... Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, ... analyzes and studies the major market drivers, restraints, ... and the Rest of the world (RoW). ... to reach $3.58 billion by 2019 from $2.4 ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 ... that specializes in providing online solutions to ... today it has achieved full accreditation for ... Network Accreditation Program (HNAP) from the Electronic ... EHNAC’s HNAP accreditation runs in two-year increments ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Saves Members, Health System a Record $45.4 Million through Anti-fraud Efforts 2Health News:New Way to Evaluate Meniscus Tear Outcomes 2Health News:Burns Engineering Now Offers 3-Day Quick Ship on Sanitary RTDs and Thermocouples 2Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 2Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 3Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 4Health News:DentalXChange Achieves EHNAC Healthcare Network Accreditation for Fifth Consecutive Time 2Health News:DentalXChange Achieves EHNAC Healthcare Network Accreditation for Fifth Consecutive Time 3
... Medial Saude S/A,(BOVESPA: MEDI3) (MEDIAL SAUDE) announces the following webcast: , , ... Friday, August 14, 2009 at 12:00 PM ET, ... Live over the Internet -- Simply log on to the web at the, ... Conference call dial-in phone numbers:, Toll-free from the US: (1 888) ...
... , , INDIANAPOLIS, Aug. 3 ... by Adventist Health System as its exclusive clearinghouse for physicians. ... portal-based clearinghouse/Revenue Cycle Management Services to improve Adventist Health System,s ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090701/RMLOGO ...
... ... Plastic Surgery Societies Reveals Surprising Answers , ... New York, NY and Arlington Heights, IL (Vocus) August 3, 2009 -- What ... person. That,s just one finding from a recent consumer survey conducted on the BeautyforLife ...
... INCLINE VILLAGE, Nev., Aug. 3 PDL BioPharma, Inc. (PDL) ... E. ("Barry") Selick, Ph.D., to the Company,s Board of Directors. , ... and his extensive knowledge of PDL,s humanization technology will allow him ... seek to maximize the value of our antibody humanization patents and ...
... HATBORO, Pa., August 3 InfoLogix, Inc. ... of enterprise mobility solutions for the healthcare and commercial industries, ... healthcare providers, the InfoLogix M24 mobile clinical assistant: a powerful ... patient information at the point-of-care. , , ...
... LITTLE FALLS, N.J., Aug. 3 CANTEL MEDICAL ... Purification subsidiary, has continued the expansion of its water purification and ... Systems Int,l, LLC. G.E.M. designs, builds, installs and services high ... The acquired business had pre-acquisition revenues of approximately $3.5 million. ...
Cached Medicine News:Health News:RealMed Named Exclusive Medical Claims Clearinghouse for Physicians by Adventist Health System 2Health News:RealMed Named Exclusive Medical Claims Clearinghouse for Physicians by Adventist Health System 3Health News:How Do Our Attitudes About Beauty Change As We Age? 2Health News:How Do Our Attitudes About Beauty Change As We Age? 3Health News:How Do Our Attitudes About Beauty Change As We Age? 4Health News:PDL BioPharma Elects Barry Selick to Its Board of Directors 2Health News:New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records (EMR) Directly at the Point of Care 2Health News:New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records (EMR) Directly at the Point of Care 3Health News:Cantel Medical's Mar Cor Purification Subsidiary Acquires G.E.M. Water Systems ... Establishing a Nationwide Reach in Water Treatment 2Health News:Cantel Medical's Mar Cor Purification Subsidiary Acquires G.E.M. Water Systems ... Establishing a Nationwide Reach in Water Treatment 3
The unique design of the TWINFIX Suture Anchors combines high resistance to pullout from our patented thread design with optimal knot tying from the DURABRAID suture....
... Micro Anchor is the smallest, strongest ... flexibility in placement into even the ... with 3-0 or 4-0 ETHIBOND EXCEL ... or cutting swaged needles. The kit ...
The Mini Anchor is an exceptionally strong, versatile anchor. This anchor comes in either a load-your-own or QUICKANCHOR format, preloaded on either 2/0 or 0 ETHIBOND EXCEL suture with swaged needles...
... Threaded Anchors (3.0mm) are ideal for soft tissue ... surgical applications. The FASTIN threaded anchor technology offers ... surgical sites. If you need a threaded anchor ... the FASTIN anchor is the anchor for you. ...
Medicine Products: